REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $562,236 | +4.7% | 20,312 | +1.2% | 0.00% | 0.0% |
| Q2 2023 | $536,846 | +50.1% | 20,069 | +21.5% | 0.00% | +100.0% |
| Q1 2023 | $357,628 | -11.9% | 16,511 | -3.1% | 0.00% | 0.0% |
| Q4 2022 | $405,988 | +32.2% | 17,044 | +9.4% | 0.00% | 0.0% |
| Q3 2022 | $307,000 | +22.3% | 15,586 | +21.2% | 0.00% | 0.0% |
| Q2 2022 | $251,000 | -47.7% | 12,863 | -31.6% | 0.00% | 0.0% |
| Q1 2022 | $480,000 | -18.4% | 18,817 | -19.4% | 0.00% | 0.0% |
| Q4 2021 | $588,000 | -8.4% | 23,352 | +0.1% | 0.00% | -50.0% |
| Q3 2021 | $642,000 | -29.3% | 23,329 | -18.4% | 0.00% | -33.3% |
| Q2 2021 | $908,000 | -7.4% | 28,603 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $981,000 | +31.9% | 21,379 | +13.8% | 0.00% | 0.0% |
| Q4 2020 | $744,000 | – | 18,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |